Back to search
FDAFDA · Food and drugs·Recall number D-1098-2018

Valsartan, 320mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46256. NDC: 51655-0654-52

Published August 22, 2018 · Recall initiated: July 18, 2018

Summary

FDA records drug Class II recall D-1098-2018, published August 22, 2018 and initiated July 18, 2018. Recalling firm: Northwind Pharmaceuticals LLC; Status: Terminated; Reported quantity: 14 bottles; Lot: Lot: UT48100001, exp 9/30/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Northwind Pharmaceuticals LLC
Distributor
Indiana
Lot
Lot: UT48100001, exp 9/30/2019
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Valsartan, 320mg, 30 tablets per bottle, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46256. NDC: 51655-0654-52 recalled?

Yes. FDA published recall D-1098-2018 on August 22, 2018. Reported hazard: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

What should I do if I have this product?

Voluntary: Firm initiated · Letter